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Objective: To investigate the application of optical coherence tomography angiography
(OCTA) in cerebral small vessel disease (SVD), ischemic stroke and dementia.
Methods: We conducted a systematic search in MEDLINE (from inception) and
EMBASE (from 1980) to end 2019 for human studies that measured retinal parameters
in cerebral SVD, ischemic stroke, and dementia using OCTA.
Results: Fourteen articles (n = 989) provided relevant data. Ten studies included
patients with Alzheimer disease (AD) and mild cognitive impairment (n = 679),
two investigated pre-symptomatic AD participants (n = 154), and two investigated
monogenic SVD patients with cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy (n = 32) and Fabry disease (n =
124). Methods to reduce bias and risk factor adjustment were poorly reported.
Substantial methodological variations between studies precluded a formal meta-analysis.
Quantitative measurements revealed significant yet inconclusive changes in foveal
avascular zone, perfusion density, and vessel density (VD) in AD, presymptomatic AD,
and SVD patients. Two (n= 160) of three studies (n= 192) showed association between
decreased VD and increased white matter hyperintensities. In three (n = 297) of seven
studies (n= 563), better cognitive function was associated with increased VD. One study
(n = 52) suggested increased VD was associated with increased ganglion cell–inner
plexiform layer thickness in AD yet with no covariate adjustment.
Conclusions: Changes in retinal microvasculature identified using OCTA are associated
with monogenic SVD and different stages of AD, but data are limited and partly
confounded by methodological differences. Larger studies with risk factors adjustment
and more consistent OCTA methods are needed to fully exploit this technology.
PROSPERO registration number: CRD42020166929.
Keywords: dementia, Alzheimer’s disease, retinal vasculature, optical coherence tomography angiography,
ischemic stroke, cerebral small vessel disease
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INTRODUCTION
Cerebral small vessel disease (SVD) is an intrinsic disorder that
affects the brain’s small perforating arterioles, capillaries, and
probably venules, causing various lesions seen on pathological
examination or brain imaging with magnetic resonance imaging
(MRI) or computed tomography (1). Cerebral SVD is a common
condition in older adults and causes a wide array of clinical
syndromes, including 25% of ischemic strokes and 80% of
intracerebral hemorrhages, and contributes to up to 50% of
dementias worldwide (1–3).
However, the changes in the cerebral microcirculation are
difficult to visualize in vivo. Because the retinal microvasculature
and cerebral microvasculature share similar embryologic
origins as well as anatomical and physiological properties
(4), investigating the network of retinal vessels may provide
new insights into cerebrovascular disease and the vascular
contribution to pathologic features of dementia (5). Previous
literature has mainly focused on retinal fundus photography or
optical coherence tomography (OCT) (5, 6).
A newly presented extension of structural OCT, referred
to as optical coherence tomography angiography (OCTA),
represents a novel non-invasive, depth-selective modality that
allows for visualization of retinal blood flow without dye
injection (7). OCTA images are essentially motion-contrast
images, which are based on the different backscattering of
light between red blood cells and neurosensory tissue, because
red blood cells are moving while neurosensory tissue is
static (8). In many cases, these images are now approaching
histology-level resolution (8), raising great interest in the
possibility of detecting early microvascular pathological changes
in people in vivo. A comprehensive review of the technology,
its principles, limitations, and the clinical application in eye
disease has been published (8), work that we extend here
into the arena of neurological disease. OCTA may permit
detection of a series of changes such as reduction in capillary
vessels and perfusion density before they are visible on retinal
photographs (9). Moreover, recent work suggests that high-
resolution OCTA images combined with machine learning may
provide great potential to automate detection and quantification
of microvascular changes underlying common brain diseases
such as SVD, stroke, and dementia, in the future (10, 11).
In this study, we aimed to conduct a systematic review of
the literature to examine the application of OCTA in cerebral
SVD, ischemic stroke, and dementia, including Alzheimer
disease (AD), vascular dementia, frontotemporal dementia, and
dementia with Lewy bodies. Specifically, our primary objective is
to find out whether there are any specific changes seen in patients
with cerebral SVD, ischemic stroke, and/or dementia using
OCTA when compared with healthy individuals. Our secondary
objective is to assess the association between OCTA changes and
brain imaging findings, cognitive functions, and other retinal
parameters using fundus camera imaging or standard OCT.
METHODS
This systematic review was based on a predefined protocol
(PROSPERO registration no. CRD42020166929) following the
Preferred Reporting Items for Systematic Reviews and Meta-
analyses (12) guidelines.We refer to SVDMRI findings according
to STRIVE (Standards for Reporting Vascular Changes on
Neuroimaging) guidelines (13). As all analyses here are based
on publicly available summary statistics and not individual-
level data, no ethical approval or informed patient consent
was required.
Search Strategy
We conducted a literature search of the Medical Literature
Analysis and Retrieval System Online (MEDLINE, from
inception) and the Excerpta Medica Database (EMBASE,
from 1980) up to December 31, 2019, using the Ovid Web
Gateway (detailed search strategy in Supplementary Material).
We considered only studies published in English. References
of relevant articles were hand-searched, and a forward citation
search was performed to identify further studies.
Inclusion and Exclusion Criteria
The studies included patients with cerebral SVD, ischemic stroke,
and/or any type of dementia and compared either (1) retinal
parameters using OCTA vs. control, (2) OCTA parameters and
brain imaging findings, (3) OCTA parameters and cognitive
function, or (4) OCTA parameters and findings on fundus
camera imaging or OCT.
The following studies were excluded: (1) duplicate
publications or studies not meeting the inclusion criteria,
(2) review studies, (3) single-case reports, (4) nonhuman studies,
(5) non–English language studies, (6) conference presentations
or summaries, (7) studies without details of diagnosis criteria
or definitions, and (8) studies that despite examining retinal
parameters did not conduct or report results on OCTA.
Data Extraction
We initially screened all studies identified in the systematic search
by abstract and title for potentially relevant articles. Duplicate
articles were removed, and the remaining articles were assessed
for eligibility after full-text review. Data extracted from these
studies included title; authors; publication year; study aim; study
type; number of patients and controls; number of male and
female, mean age, participant selection criteria, and diagnostic
criteria; type of OCTA device; assessment of OCTA image quality;
whether OCTA associations were adjusted for demographics,
other risk factors, or other covariates; and outcomes. All data
were cross-checked by a second reviewer. We report covariate-
adjusted associations when available.
Quality Assessment
We used the STROBE checklist (www.equator-network.org) to
score study methodology and assess study quality. We assigned
up to 22 points using this checklist. This score was applied
after study inclusion and did not influence whether a study was
included in the review.
Owing to the small number of studies per category and
the large methodological heterogeneity, it was not possible to
combine study data by meta-analysis.
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RESULTS
The search returned 2,611 articles. One additional article was
found by hand-search. Among them, 621 duplicate articles were
removed. The remaining 1,991 articles were screened by title and
abstract only. Of those, 16 were considered potentially relevant
and were assessed by full-text review. Figure 1 details numbers
of articles excluded and the reasons.
Fourteen articles met the inclusion criteria. The population
samples came from the United States (five articles), the
Netherlands (two articles), Germany (two articles), Italy (two
articles), Poland (one article), Turkey (one article), and China
(one article). Multiple articles from the same study population
were included only if different retinal parameters or outcomes
were measured in separate articles.
Study Design and Patient Characteristics
Table 1 summarizes the study design and patient characteristics
from the articles included. The 14 articles (14–27) included
comprised 13 cross-sectional studies and 1 case–control study.
Although two articles (18, 19) had overlapping samples, each
study assessed different outcomes. Across the included studies
(if two articles had an overlapping study population, the study
with the larger sample was chosen), the total number of unique
participants was 989. Participants in each study varied from 16 to
213 (median n= 55).
Ten articles (14–23) included patients with AD and
mild cognitive impairment (MCI) (AD, n = 221; MCI, n =
106; controls, n = 352). Two studies (24, 25) investigated
presymptomatic AD participants who had normal cognitive
function with positive biomarker of amyloid-β (Aβ) (total
n = 154). No relevant studies were identified for other
types of dementia. Two studies investigated monogenic SVD
patients: one (26) studied cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoencephalopathy
(CADASIL) patients (CADASIL, n = 11; controls, n = 21),
and the other (27) studied Fabry disease (Fabry disease,
n = 54; controls, n = 70). We did not find any study on
FIGURE 1 | Search strategy flow chart.
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TABLE 1 | Study design and patient characteristics.
Article Design of
study
Number of subjects (eyes) Eye selection Mean age ± SD (years) Sex (Male/Female) MMSE (Mean)
AD studies Patients HC Patients HC Patients HC Patients HC
Bulut et al. (14) Cross-sectional
study
AD 26 (26) 26 (26) One eye from each subject was
randomly selected
AD 74.2 ± 7.6 72.6 ± 6.3 AD 11/15 13/13 AD 17 27
Lahme et al.
(15)
Cross-sectional
study
AD 36 (36) 38 (38) — AD 68.0 ± 9.3 66.1 ± 10.1 AD 15/21 14/23 AD 22 —
Haan et al. (16) Cross-sectional
study
AD 48 (NA) 38 Values from both eyes were averaged
unless only one eye was suitable
AD 65.4 ± 8.1 60.6 ± 5.0 AD 25/23 24/14 AD 23 29
Querques et al.
(17)
Cross-sectional
study AD 12 (12)
MCI 12 (12)
32 (32) One eye for each subject was
randomly selected AD 72.9 ± 7.2
MCI 76.3 ± 6.9
71.6 ± 5.9
AD 4/8
MCI 5/7
17/15
AD 21
MCI 25
—
Yoon et al. (18)* Cross-sectional
study AD 39 (70)
MCI 41 (79)
133 (254) Eye images with poor scan quality
and motion artifact were excluded AD 72.8 ± 7.7
MCI 71.1 ± 7.6
69.2 ± 7.8
AD 13/26
MCI 17/20
36/97
AD 20
MCI 23
29
Yoon et al. (19)* Cross-sectional
study AD 9 (17)
MCI 7 (13)
— Values from both eyes were averaged
unless only one eye was suitable AD 75.2 ± 7.5
MCI 70.7 ± 9.1
—
AD 4/5
MCI 4/3
—
AD 22
MCI 26
—
Zabel et al. (20) Cross-sectional
study
AD 27 (27) 27 (27) One eye of each patient was included AD 74.1 ± 5.9 74.3 ± 7.7 AD 6/21 8/19 AD 21 28
Jiang et al. (21) Cross-sectional
study AD 12 (NA)
MCI 19 (NA)
21 Values from both eyes were averaged
AD 73.3 ± 9.6
MCI 69.6 ± 9.8
67.6 ± 8.3
AD 7/5
MCI 7/12
7/14
AD 20
MCI 26
30
Wu et al. (22) Cross-sectional
study AD 18 (28)
MCI 21 (32)
21 (33) Eye images with poor scan quality
and motion artifact were excluded AD 69.9 ± 6.4
MCI 67.8 ± 6.0
68.7 ± 5.9
—
MCI 12/9
11/10
AD 20
MCI 25
27
Zhang et al. (23) Cross-sectional
study
aMCI/eAD
16 (16)
16 (16) Chose right eyes. If the image quality
failed, then chose left eyes.
aMCI/eAD 73.03
± 8.24
73.6 ± 7.7 aMCI/eAD
3/13
3/13 MoCA
20
MoCA
27
Presymptomatic AD studies
van de Kreeke,
et al. (24)
Cross-sectional
study
Aβ+ 13 Aβ- 111 Values from both eyes were averaged ALL 68.6 ± 6.3 ALL 58/66 ALL 29
O’Bryhim et al.
(25)
Case–control
study
ALL 30 (58) Eye images with poor scan quality
and motion artifact were excluded
ALL 74.5 ± 5.6 ALL 14/16 (normal)
CADASIL study CADASIL HC CADASIL HC CADASIL HC CADASIL HC
Nelis et al. (26) Cross-sectional
study
11 (21) 21 (21) Values from both eyes were used. 53.5 ± 10.7 53.8 ± 11.5 3/8 — — —
Fabry disease study Fabry HC Fabry HC Fabry HC Fabry HC
Cennamo et al.
(27)
Cross-sectional
study
54 (54) 70 (70) One eye for each subject was
randomly selected
44.1 ± 15.6 42.3 ± 15.6 20/34 34/36 — —
AD, Alzheimer disease; MCI, mild cognitive impairment; HC, healthy control; eAD, early Alzheimer-type dementia; aMCI, amnestic type of MCI; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; CADASIL,
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
*The two studies were from the same study population.
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FIGURE 2 | Study populations in reviewed studies. AD, Alzheimer disease;
MCI, mild cognitive impairment; CADASIL, cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoencephalopathy.
sporadic SVD or ischemic stroke that met the inclusion
criteria (Figure 2).
Quality Assessment
The median study quality score as per STROBE checklist (www.
equator-network.org) was 16/22 (Supplementary Table 1).
Scores were mainly affected by inadequate description of study
design in title or abstract, not explaining rationale for study
size, inadequate description of efforts made to control potential
sources of bias, and inadequate discussion of generalizability
of results.
OCTA Devices, Parameters, and
Calculation Method
Table 2 summarizes the methods used by each study to assess
retinal parameters. Eight articles (14, 15, 20, 22, 23, 25–
27) used AngioVueTM system of Optovue, and the other
six articles (16–19, 21, 24) used AngioPlexTM of Carl Zeiss.
Different manufacturers use different hardware, software, and
algorithms for vessel segmentation, which complicates interstudy
comparisons, and indeed, OCTA parameters with the same
name may be defined differently across studies. Furthermore,
different studies used different image quality assessment methods
or cutoffs (Supplementary Table 2). Therefore, the results from
those studies are not all interchangeable (28). See Table 3 for
detailed explanation of these retinal parameters.
Main Analysis
OCTA Parameters in Patients vs. Controls
Figure 3 and Table 4 summarize the main results from the
14 included studies. Eight studies (14, 16, 18, 20, 22, 24–26)
compared the foveal avascular zone (FAZ) size between patients
and controls. Four studies [n = 196, median n = 53, three AD
andMCI studies (14, 20, 22); one presymptomatic AD study (25)]
found that patients had enlarged FAZ compared with controls.
Among these studies, two (14, 22) were age- and sex-matched;
another (25) adjusted for age, sex, scan quality, and diabetes;
and the other (20) did not adjust for any covariates. Four other
studies [n = 455, median n = 105, two AD and MCI studies
(16, 18); one presymptomatic AD study (24); one CADASIL
study (26)] showed no difference between patient and control
groups. Among these studies, one study matched for age and sex
(18). Two studies (16, 24) adjusted for age, one (16) of which also
adjusted for spherical equivalent, and quality factor. The other
study (26) did not adjust for any covariates.
Twelve studies (14–18, 20–24, 26, 27) compared the
vascular density parameters (vessel density, vessel length density,
perfusion density, etc.) between patients and controls. From
these, eight studies [n= 569, median n= 53, seven AD and MCI
studies (14, 15, 18, 20–23); one CADASIL study (26)] suggested
decreased vascular density parameters in patients compared with
controls. Among them, two studies (20, 21) did not adjust for any
covariates, one study (18) adjusted the results for age and sex, and
in four studies (14, 15, 23, 26), sample groups were matched for
age, three of which (14, 22, 23) also matched for sex and one of
them (23) also matched for race. However, two studies [n = 56
and n = 86, involving AD and MCI patients (16, 17)] showed
no difference between patient and control groups. Interestingly,
one study in presymptomatic AD (n = 124) (24) found Aβ+
participants had higher vessel density than Aβ- participants after
adjusting for age. Another study (n = 124) (27) found Fabry
disease patients had decreased vascular density in superficial
capillary plexus and increased in deep capillary plexus compared
with controls after adjusting for age and sex.
OCTA Parameters in Relation to Brain Imaging
Findings
Only four studies [n = 208, median n = 53, three in AD and
MCI (15, 16, 19) and one in CADASIL (26)] investigated the
relationship between OCTA findings and brain imaging findings.
Two of them (n= 74 and n= 86) (15, 16) involving AD andMCI
participants found increased vessel density (VD) was associated
with having fewer white matter hyperintensities (WMHs), as per
Fazekas scores. Between these two studies, one (15) matched for
age, and the other (16) adjusted for age and sex. One study (n =
16) (19) involving AD and MCI patients suggested a potential
association between decreased VD and decreased perfusion
density with increased volume of the inferior lateral ventricle
(temporal horn), but it did not control for covariates, and patients
and controls were not matched by age and/or gender. The study
(n= 32) (26) in CADASIL patients found no association between
OCTA parameters and the number of small infarcts or WMHs,
the latter estimated using Fazekas scores.
OCTA Findings in Relation to Cognitive Function
Seven (14–16, 18, 20, 21, 23) studies investigated the relationship
between OCTA parameters and cognitive function in AD and
MCI participants. Three studies (n = 297) (14, 18, 23) suggested
better cognitive function was associated with increased VD. One
study (n = 52) (14) found enlarged FAZ area was associated
with decreased Mini-Mental State Examination (MMSE) scores.
Of these three studies, two (14, 23) were age- and sex-matched,
one of which (23) was also race-matched. One study (18) did not
adjust or match for covariates. However, four other studies (n =
266, median n= 64) (15, 16, 20, 21) found no association between
OCTA parameters and cognitive functions. Among them, one
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TABLE 2 | OCTA devices, parameters, and calculation method.
Article OCTA
device
Macular
scan size
(mm)
ONH scan
size (mm)
OCTA parameters Additional
adjustments
Bulut et al.
(14)
Optovue 6 — VD (%): Whole/fovea/parafovea superficial VD
FAZ (mm2 )
Flow index rates: outer retina/choroidal flow rate
None (age and sex
matched)
Lahme
et al. (15)
Optovue 3 4.5 VD (%): Whole/fovea/parafovea superficial VD
Whole/fovea/parafovea deep VD
Whole radial peripapillary capillaries/radial peripapillary capillaries VD
None (age matched)
Haan et al.
(16)
Zeiss 6 — VD (/mm): inner ring (Ø 1–3mm around fovea) VD
Outer ring (Ø 3–6mm around fovea) VD
FAZ (mm2 )
Age, spherical
equivalent, and quality
factor
Querques
et al. (17)
Zeiss 3
6
— PD (%), 3 and 6mm
Superficial/deep vascular plexus -PD
Choriocapillaris/choroida -PD
None (age and sex
matched)
Yoon et al.
(18)
Zeiss 3
6
— Superficial vascular plexus of VD (/mm) and PD (%) in:
3-mm circle, 3-mm ring (Ø 1–3mm around fovea), and
6-mm circle
FAZ (mm2 )
Age and sex
Yoon et al.
(19)
Zeiss 3
6
— VD (/mm) and PD (%):
6 * 6 mm: 6-mm circle, 3-mm ring (Ø 1–3mm around fovea) and
6-mm ring (Ø 3–6mm around fovea)
3 *3 mm: 3-mm circle and 3-mm ring (Ø 1–3mm around fovea)
FAZ (mm2 )
None
Zabel et al.
(20)
Optovue 6 4.5 VD (%): Whole superficial/deep-VD,
Whole radial peripapillary capillaries VD
Radial peripapillary capillaries VD
FAZ (mm2 )
None
Jiang et al.
(21)
Zeiss 3 — VD (Dbox):
Area: ring (Ø 0.6–2.5mm around fovea),
Further separate (a), into four quadrantal sectors
(b), into six concentric rings
Segmentation: total, superficial and deep layers
None
Wu et al.
(22)
Optovue 6 — VD (%):
1.5-mm ring (Ø 0.3–1.5mm around fovea)
3-mm ring (Ø 1.5–3mm around fovea)
Each ring was separated into four quadrantal sectors
FAZ (mm2 ).
None (age and sex
matched)
Zhang
et al. (23)
Optovue 3 4.5 VD (%) and VLD (%):
Parafoveal superficial capillary plexus VD/VLD,
Peripapillary radial peripapillary capillary VD/VLD
Peripapillary superficial vascular plexus VD/VLD
Adjusted flow index: Parafoveal superficial capillary plexus
None (age, sex and race
matched)
van de
Kreeke,
et al. (24)
Zeiss 6 — VD (/mm): inner ring (Ø 1–3mm around fovea) VD
outer ring (Ø 3–6mm around fovea) VD
ONH ring (Ø 3–6mm around the ONH) VD
FAZ (mm2 )
Age
O’Bryhim
et al. (25)
Optovue 6 — FAZ (mm2 ) Age, gender, scan
quality, and diagnosis of
diabetes
Nelis et al.
(26)
Optovue 3 4.5 FAZ (mm2 ) (separated into superficial and deep layers)
VD (%): Parafoveal superficial/deep VD and OND VD
Choriocapillaris [CC] parameters:
Choriocapillaris (CC) decorrelation index (%)
Choriocapillaris flow area (%)
Analysis of signal voids
None (age matched)
Cennamo
et al. (27)
Optovue 6 — VD (%): Superficial AND Deep capillary plexus:
Whole image/parafovea/fovea VD
Age and sex
AD, Alzheimer disease; MCI, mild cognitive impairment; HC, healthy control; eAD, early Alzheimer-type dementia; aMCI, amnestic type of MCI; CADASIL, Cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoencephalopathy, OCTA, optical coherence tomography angiography; ONH, optic nerve head; VD, vessel density; VLD, vessel length
density; PD, perfusion density; FAZ, foveal avascular zone; ANOVA, analysis of variance.
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TABLE 3 | OCTA retinal parameters assessed by reviewed studies.
OCTA retinal parameters Descriptions Study
Foveal avascular zone (FAZ) (mm2 ) The central avascular region in human foveola is known as the foveal avascular zone (FAZ) (14, 16, 18–20, 22, 24–26)
Perfusion density (PD) (%) In most Carl Zeiss devices, PD (%) was defined as the total area of perfused retinal
microvasculature per unit area in a region of measurement
(17–19)
Vessel density or vascular density (VD) In most Optovue devices, VD (%) has the similar definition of PD in Carl Zeiss device (14, 15, 20, 22, 23, 26, 27)
In most Carl Zeiss devices, VD (/mm) was defined as the total length of perfused retinal
microvasculature per unit area in the region of measurement
(16, 18, 19, 24)
VD (Dvox) is analyzed using fractal analysis with box counting (Dbox) (21)
Vessel length density (VLD) VLD (%) (using Optovue device) represents the ratio of the total length occupied by all the
blood vessels in a given area to the total area. All vessels were then skeletonized into
1-pixel-wide vessels
(23)
Adjusted flow index or flow index rate
or decorrelation signal index
Adjusted flow index, a surrogate measure of blood flow velocity in OCTA, is defined as the
average decorrelation value of all pixels above the noise threshold (only “vessels”) in the en
face angiogram. Adjusted flow index and flow index rate have no unit, while the
decorrelation signal index is “%”
(14, 23, 26)
Choriocapillaris flow area (%) The choriocapillaris vascular flow area was defined as the percentage of the portion of
white pixels against the whole scan area
(26)
Analysis of signal voids in
choriocapillaris area (µm2)
The proportion of absent flow signal accounted for by signal voids >10,000 µm2
(FV10000) and signal voids >40,000 µm2 (FV40000) were evaluated
(26)
study (16) found no association, both adjusted and unadjusted
for age and sex, whereas the other three studies (15, 20, 21) did
not match or adjust for covariates.
OCTA Parameters and Other OCT/Fundus Imaging
Parameters
Only one study (n = 52) (21) explored the relationship between
OCTA features and OCT findings in patients with AD and found
that increased VD was associated with increased ganglion cell–
inner plexiform layer (GC-IPL) thickness. However, this study
did not adjust or match for any covariates. None of the studies
included investigated the relationship betweenOCTA parameters
and traditional fundus imaging.
DISCUSSION
This systematic review found 14 studies investigating OCTA
in patients with cerebral SVD or dementia, published between
2017 and 2020. These studies mainly focused on AD and MCI,
pre-symptomatic AD, and monogenic SVD including CADASIL
and Fabry disease. No other dementias, ischemic stroke, or
sporadic SVD studies met the inclusion criteria. There were no
longitudinal studies. Collectively, these studies do not provide
a clear conclusion of whether the retinal microvasculature is
impaired in cerebral SVD, ischemic stroke, and dementia patients
or not.
FAZ is a capillary-free area in the foveal zone susceptible
to ischemia (29). Enlargement of FAZ is a sign of ischemia
(14). The analysis of the FAZ measurements yielded inconclusive
results. Four studies (n = 196) (14, 20, 22, 25) found increased
FAZ in patients compared with controls, whereas four other
studies (n = 455) (16, 18, 24, 26) showed no difference
between groups. It is possible that the relatively small sample
size of some studies precludes detection of group differences.
Another possibility is that some studies included patients in
the earlier stage of the disease process, which might explain
why no FAZ difference was found between groups (24).
However, as ophthalmological confounders, quality factors, and
other possible risk factor confounders including age were not
always taken into account, studies reporting group differences
may represent an overestimation of true disease effects (16).
Furthermore, significant variation in FAZ area in normal eyes
has been reported that may be associated with gender, central
retinal thickness, etc. (30). Therefore, studies with larger sample
size and good matching of potential confounders are needed to
further verify these findings. Also, the lack of longitudinal studies
means that it is difficult to know if the early OCTA changes could
predate worsening neurological state, and longitudinal studies
are urgently needed.
The decreased vascular density (including parameters such
as VD, perfusion density, vessel length density, etc.) is another
sign of microvasculature impairment. Eight studies (n = 569,
seven with AD and MCI and one with CADASIL) (14, 15,
18, 20–23, 26) suggested decreased vascular density parameters
in patients compared with controls. However, two studies
(n = 56–86) (16, 17) showed no difference between groups.
Different sample size, disease stage, and confounder adjustment
might explain the disparity in results. Interestingly, van de
Kreeke et al. (n = 124) (24) found Aβ+ participants had
higher VD than Aβ- participants in pre-symptomatic AD. Here,
early amyloid accumulation in the retina might induce an
inflammatory reaction with hypoxia, leading to increased retinal
blood flow (24). Larger studies including those following patients
longitudinally will help explore retinal vessel changes. Moreover,
Cennamo et al. (n = 124) (27) found Fabry disease patients had
decreased VD in superficial capillary plexus and increased VD
in deep capillary plexus compared with the control group. The
authors considered the increased VD in deep capillary plexus
as a compensatory mechanism to support the reduced VD in
superficial capillary plexus (27).
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FIGURE 3 | Finding summaries of reviewed studies. OCTA, optical coherence
tomography angiography; OCT, optical coherence tomography; FAZ, foveal
avascular zone; VD, vessel density.
We further explored the relationships between OCTA and
brain imaging findings. Currently, cerebral small vessels are hard
to visualize in vivo. Other imaging features are provided as SVD
biomarkers such as WMHs, microbleeds, enlarged perivascular
spaces, and lacunes (1). Because the retinal vasculature is a proxy
of cerebral vessels (4), establishing the relationship between
retinal microvasculature and cerebral imaging findings could aid
in our understanding of disease mechanisms. This systematic
review found only four studies (15, 16, 19, 26) that investigated
the relationship between OCTA parameters and brain imaging
findings of SVD. Two studies (n = 74–86) (15, 16) found
decreased VDwas associated withmoreWMHs, whereas another
study (n = 32) (26) found no association between OCTA
parameters and WMHs or the number of small infarcts, which
might be due to small sample size. MRI changes, such as atrophy
of the brain and consequential ventricular enlargement, can
be seen in AD or SVD patients (31). A pilot study (n = 16)
(19) suggested the potential association between decreased VD
and perfusion density with increased volume of inferior lateral
ventricle (temporal horn). These small sample studies show a
promising role of OCTA to investigate SVD in vivo. A prospective
cross-sectional study (32) published recently when our work
was under review investigating the amyloid-positive AD-related
cognitive impairment (n = 28), subcortical vascular cognitive
impairment (n = 18) patients, and amyloid-negative cognitively
normal subjects (n= 14) found that VDwas negatively correlated
with SVD scores and suggested OCTA as a potential imaging tool
to screen for the degree of SVD. Further studies in larger samples
comparing a range of SVD brain imaging biomarkers with OCTA
parameters are needed to confirm relationships and explore the
underlying pathophysiological mechanisms in SVD.
Previous studies reported that the changes in retinal vessel
caliber on fundus imaging were associated with cognitive decline
(5). This systematic review found seven studies investigated the
relationship between OCTA findings and cognitive function.
Among them, three studies (n = 297) (14, 18, 23) suggested
better cognitive function was associated with higher VD. One
study (n = 52) (14) found enlarged FAZ area was associated
with decreased MMSE score. However, four other studies (n
= 266) (15, 16, 20, 21) found no association between OCTA
parameters and cognitive function. A cross-sectional study
(33) in 27 amnestic mild cognitive impaired patients and 29
controls published after completing this review did not find
any correlation between MMSE scores and OCTA parameters.
Contradictory results, relatively small samples with limited or
no adjustment for covariates, and no long-term follow-up of the
studies that suggest OCTA parameters as potential predictors of
cognitive decline point to the necessity of larger, longitudinal
studies in this area of research.
We found only one study (n = 52) (21) investigating the
relationship between OCTA features and OCT findings that
suggested increased VD was associated with increased GC-IPL
thickness in AD patients. However, this study did not adjust
for covariates. The optic nerve and retina develop as a direct
extension of the diencephalon during embryonic development
(4). OCT is a non-invasive method and offers high-resolution
images of the retinal structure, including the neuronal layers (6).
Exploring the relationship between OCT and OCTA findings
especially in longitudinal studies will not only provide evidence
of the temporal changes between retinal nerve layers and
retinal microvasculature, but also offer potential predictors in
disease progression.
We did not find any study investigating the relationship
between OCTA parameters and fundus imaging. Retinal
arterioles and venules typically measure 15 to 150µm in size,
whereas the capillaries measure 5 to 15µm (34). There is
an extensive literature studying the retinal vessel changes in
SVD, ischemic stroke, and dementia using fundus imaging
(5, 35). However, recent fundus imaging can only measure
relatively large retinal vessels, whereas OCTA provides
high-resolution, depth-resolved information that has been
available only since 2016 (8). The relationships between
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TABLE 4 | Results of included studies.
Article OCTA parameters in subjects vs. controls OCTA and brain
imaging findings
OCTA and cognitive function OCTA and
fundus or OCT
images
Bulut et al. (14)
(n = 52)
The group of patients with AD had lower VD and
enlarged FAZ area compared with the control
group
Not assessed Increased MMSE score associated
with all increased VD parameters
and decreased FAZ area
Not assessed
Lahme et al. (15)
(n = 74)
The group of patients with AD had lower VD
compared with control group
Increased VD
associated with
decreased Fazekas
score
No association between MMSE
score and VD
Not assessed
Haan et al. (16)
(n = 86)
No difference between AD and control groups Increased VD
associated with
decreased Fazekas
score
No association between MMSE
score and OCTA parameters
Not assessed
Querques et al. (17)
(n = 56)
No differences were found among groups Not assessed Not assessed Not assessed
Yoon et al. (18)
(n = 213)
The AD group showed reduced VD and PD
compared with MCI group and control group
No difference between MCI and control groups
Not assessed Increased MMSE score associated
with increased VD and PD
parameters
No association between MMSE
score and FAZ
Not assessed
Yoon et al. (19)
(n = 16)
Not assessed Decreased VD and PD
with increased volume
of inferolateral ventricle
Not assessed Not assessed
Zabel et al. (20)
(n = 54)
AD group showed reduced VD and increased FAZ
compared with control group
Not assessed No association between MMSE
score and OCTA parameters
Not assessed
Jiang et al. (21)
(n = 52)
AD group showed reduced VD compared with
control group
Not assessed No association between MMSE
score and VD
Increased VD
associated with
increased GC-IPL
thickness in AD
patients
Wu et al. (22)
(n = 60)
The patient groups had lower VD and enlarged
FAZ area compared with the control group
Not assessed Not assessed Not assessed
Zhang et al. (23)
(n = 32)
The aMCI/eAD group showed decreased VD and
adjusted flow index compared with control group
No differences in vessel length density and FAZ
between two groups
Not assessed Increased MoCA score associated
with increased VD and vessel length
density
Not assessed
van de Kreeke et al. (24)
(n = 124)
Aβ+ participants had higher VD than Aβ-
participants
No differences in FAZ between two groups
Not assessed Not assessed Not assessed
O’Bryhim et al. (25)
(n = 30)
The FAZ was increased in the biomarker-positive
group compared with controls
Not assessed Not assessed Not assessed
Nelis et al. (26)
(n = 32)
CADASIL group showed decreased VD compared
with control group
No differences in FAZ and choriocapillaris
parameters between groups
No association between
OCTA parameters and
Fazekas score and
number of small infarcts
Not assessed Not assessed
Cennamo et al. (27)
(n = 124)
Fabry disease group showed decreased VD in
superficial capillary plexus compared with control
group
Fabry disease group showed increased VD in
deep capillary plexus compared with control group
Not assessed Not assessed Not assessed
AD, Alzheimer disease; MCI, mild cognitive impairment; HC, healthy control; MMSE, Mini-mental State Examination; MoCA, Montreal Cognitive Assessment; OCTA, Optical coherence
tomography angiography; OCT, Optical coherence tomography; FAZ, Foveal avascular zone; VD, vessel density; PD, perfusion density; VLD, Vessel length density; CADASIL, Cerebral
autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; GC-IPL, ganglion cell–inner plexiform layer.
changes in the relatively larger vessels and smaller vessels
seen only on OCTA are not fully understood. Further
studies investigating the relationship between these two
measurements are required. It should also be noted that
longitudinal studies assessing fundus images and future
neurological outcomes are also limited pointing to the need
for more longitudinal studies of OCTA and fundus images
in SVD.
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The methodological differences limit between-study
comparisons and interpretation. The variations in the different
device types, software and hardware, macular scan size,
segmentation methods, and retinal parameters all add to
heterogeneity. Other potentially confounding factors such as
age, race, and baseline status including diagnosis of diabetes are
inevitable. The asymmetry between eyes of the same individual
should be considered because it might cause potential misleading
results when we choose one eye as a proxy for both eyes (36). On
the contrary, studies utilizing both eyes of participants should
address the statistical challenges cautiously because the pair of
eyes are non-independent (36). OCTA scan quality has impacts
on derived parameters, and researchers should perform strict
quality control to ensure good data quality, and thus results are
reliable and comparable. Patients with more severe disease status
may have fixation problems, which may cause poor scan quality
(14). Lastly, studies reviewed here were cross-sectional, and no
conclusions can be drawn on the value of OCTA measurements
for evaluation of disease progression.
CONCLUSIONS
The findings of this review show promise that changes in retinal
microvasculature identified using OCTA are associated with
monogenic SVD and different stages of AD. Larger studies with
risk factors adjustment and more consistent OCTA methods are
needed to fully exploit this technology.
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GLOSSARY
OCTA, optical coherence tomography angiography; SVD,
small vessel disease; AD, Alzheimer disease; MCI, mild
cognitive impairment; CADASIL, cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoencephalopathy;
VD, vessel density, OCT, optical coherence tomography; FAZ,
foveal avascular zone; WMHs, white matter hyperintensities;
MMSE, Mini-Mental State Examination.
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